Tuesday 13 October 2026 SourcesAbout🌓
🇦🇺 AU ▾
BREAKING
Business

NeuroScientific Biopharmaceuticals clears key US Crohn’s trial hurdle

Sydney Morning Herald - Business ·
NeuroScientific Biopharmaceuticals clears key US Crohn’s trial hurdle

NeuroScientific Biopharmaceuticals has landed key US backing for its Phase 2 stem cell Crohn’s trial, green-lighting a planned year-end start subject to final preparations.

Read the full article on Sydney Morning Herald - Business ›

5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on www.smh.com.au — the content belongs to Sydney Morning Herald - Business.

More from Sydney Morning Herald - Business

See all ›

More in Business

See all ›